Evidence map›Paper›PMID 34836906›Full record

ArticleBMJ open2021

Impact of a public health intervention for active surveillance and mitigation of SARS-CoV-2 in a district from Buenos Aires province, Argentina: a descriptive epidemiological study.

Favio Crudo, Mariana Fernández, Marcelo Rodríguez Fermepín, Andrea Carolina Entrocassi, Karina Angela Cardone, Fernando Spina Markmann, Maria Victoria Periago, Roberto Chuit, Marcelo Claudio Abril

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Favio CrudoMundo Sano Foundation, Buenos Aires, Argentina.
Mariana FernándezMundo Sano Foundation, Buenos Aires, Argentina.
Marcelo Rodríguez FermepínFaculty of Pharmacy and Biochemistry, Chair of Clinical Microbiology/INFIBIOC, Buenos Aires University, Buenos Aires, Argentina.
Andrea Carolina EntrocassiFaculty of Pharmacy and Biochemistry, Chair of Clinical Microbiology/INFIBIOC, Buenos Aires University, Buenos Aires, Argentina.
Karina Angela CardoneHealth Secretariat of San Antonio de Areco, San Antonio de Areco, Buenos Aires, Argentina.
Fernando Spina MarkmannHealth Secretariat of San Antonio de Areco, San Antonio de Areco, Buenos Aires, Argentina.
Maria Victoria PeriagoMundo Sano Foundation, Buenos Aires, Argentina vperiago@mundosano.org.ORCID 0000-0002-1470-5146
Roberto ChuitInstitute of Epidemiological Research, National Academy of Medicine, Buenos Aires, Argentina.
Marcelo Claudio AbrilMundo Sano Foundation, Buenos Aires, Argentina.
Favaloro Foundation · ARUniversidad de Buenos Aires · ARInstitute of Scientific and Technical Research for Defense · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe first case of SARS-CoV-2 was reported in Argentina on 3 March 2020. Measures to limit the spread of the virus were implemented, including complete lockdown (26 March). Nonetheless, the virus spread throughout the country, with a first peak of almost a million cases in October. On 30 November, the government's recommendation switched from social, preventive and compulsory isolation, to social, preventive and compulsory distancing.

objectivesTo describe a tailored public health strategy to mitigate the spread of SARS-CoV-2 and determine its behaviour in San Antonio de Areco district from Buenos Aires province (Argentina) through a private-public association. DESIGN, SETTING AND

participantsSurveillance of the virus was performed with the local healthcare system, through early identification of cases and the systematic study of each infected individual and contact, regardless of symptomatology, using telemedicine and a COVID-19-specific outpatient clinic. Real-time PCR was used for detection using both individual and pooled samples, with a 12-hour turnaround time.

resultsUp to 30 November, a total of 2426 suspected cases were analysed and 578 were confirmed. Surveillance of health personnel and at-risk populations proved effective, mitigating viral spread. Pooling samples allowed reduction of operator time, helped reduce costs, and allowed detection of both symptomatic and asymptomatic cases.

conclusionAfter 8 months of protocol implementation, the strategy to intensively survey groups at higher epidemiological risk and the systematic search for asymptomatic cases with the incorporation of pooled PCR for diagnosis, in combination with individual testing, is an efficient and viable option in populations with similar characteristics, in the frame of social isolation.

Indexed as

COVID-19SARS-CoV-2ArgentinaCommunicable Disease ControlDelivery of Health CareEpidemiologic StudiesHumansPublic HealthWatchful WaitingCOVID-19diagnostic microbiologyepidemiologypublic health

Identifiers

PMID34836906
PMCPMC8628114
OpenAlexW3217058052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.